자동 알약 디스펜서 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Automatic Pill Dispenser Market Summary

The global automatic pill dispenser machine market size was valued at USD 3.1 billion in 2025 and is projected to grow from USD 3.4 billion in 2026 to USD 6.1 billion by 2033, at a CAGR of 8.9% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 45.5% in 2025. Rising demand for medication adherence solutions, an aging population, and increasing rates of chronic diseases require long-term treatment. The adoption of automated medication management systems in senior care facilities, homecare, pharmacies, and healthcare institutions is driving market expansion.

Market Dynamics

The automatic pill dispenser machine industry is driven by the need for efficient medication management, growth in home-based care, and advances in smart dispensing technologies. The adoption of connected devices enables scheduled dispensing, medication alerts, remote monitoring, and caregiver notifications, which help manage complex medication regimens. Demand for independent living among older adults is also increasing the use of automated dispensing systems in homes and assisted living facilities. However, high device costs, limited awareness, interoperability issues, and the need for accurate dispensing may limit adoption in price-sensitive markets.

Global Automatic Pill Dispenser Machine Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented global automatic pill dispenser machine market report based on product, end use, and region.

• Product Outlook (Revenue, USD Billion, 2021 - 2033)
• Standalone Automatic Pill Dispensers-
• Smart/Connected Automatic Pill Dispensers-
• End Use Outlook (Revenue, USD Billion, 2021 - 2033)
• Hospitals
• Senior Care facilities
• Pharmacies
• Others
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product Segment
  • 1.2.2. End Use
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Automatic Pill Dispenser Machine Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Market challenges analysis
• 3.3. Case Study Insights
• 3.4. Automatic Pill Dispenser Machine Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic landscape
    • 3.4.2.4. Environmental Landscape
    • 3.4.2.5. Legal Landscape
    • 3.4.2.6. Social Landscape

Chapter 4. Automatic Pill Dispenser Machine Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Automatic Pill Dispenser Machine Market Component Movement Analysis
• 4.3. Global Automatic Pill Dispenser Machine Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Billion)
• 4.4. Standalone Automatic Pill Dispensers
  • 4.4.1. Standalone automatic pill dispensers market estimates and forecasts, 2021 to 2033 (USD Billion)
• 4.5. Smart/Connected Automatic Pill Dispensers-
  • 4.5.1. Smart/connected automatic pill dispensers market estimates and forecasts, 2021 to 2033 (USD Billion)

Chapter 5. Automatic Pill Dispenser Machine Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Automatic Pill Dispenser Machine Market End Use Movement Analysis
• 5.3. Global Automatic Pill Dispenser Machine Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Billion)
• 5.4. Hospital
  • 5.4.1. Hospital market estimates and forecasts, 2021 to 2033 (USD Billion)
• 5.5. Senior Care Facilities
  • 5.5.1. Senior care facilities market estimates and forecasts, 2021 to 2033 (USD Billion)
• 5.6. Pharmacies
  • 5.6.1. Pharmacies market estimates and forecasts, 2021 to 2033 (USD Billion)
• 5.7. Others
  • 5.7.1. Others market estimates and forecasts, 2021 to 2033 (USD Billion)

Chapter 6. Automatic Pill Dispenser Machine Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2025 & 2033
• 6.2. Regional Market Dashboard
• 6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
• 6.4. North America
  • 6.4.1. U.S.
    • 6.4.1.1. Key country dynamics
    • 6.4.1.2. Regulatory framework
    • 6.4.1.3. Competitive scenario
    • 6.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.4.2. Canada
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.4.3. Mexico
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.5. Europe
  • 6.5.1. UK
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.2. Germany
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.3. France
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.4. Italy
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.5. Spain
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.6. Norway
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.7. Sweden
    • 6.5.7.1. Key country dynamics
    • 6.5.7.2. Regulatory framework
    • 6.5.7.3. Competitive scenario
    • 6.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.5.8. Denmark
    • 6.5.8.1. Key country dynamics
    • 6.5.8.2. Regulatory framework
    • 6.5.8.3. Competitive scenario
    • 6.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.6. Asia Pacific
  • 6.6.1. Japan
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.6.2. China
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.6.3. India
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.6.4. Australia
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.6.5. South Korea
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework
    • 6.6.5.3. Competitive scenario
    • 6.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.6.6. Thailand
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework
    • 6.6.6.3. Competitive scenario
    • 6.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.7. Latin America
  • 6.7.1. Brazil
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.7.2. Argentina
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Billion)
• 6.8. MEA
  • 6.8.1. South Africa
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Regulatory framework
    • 6.8.1.3. Competitive scenario
    • 6.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.8.2. Saudi Arabia
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework
    • 6.8.2.3. Competitive scenario
    • 6.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.8.3. UAE
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Regulatory framework
    • 6.8.3.3. Competitive scenario
    • 6.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Billion)
  • 6.8.4. Kuwait
    • 6.8.4.1. Key country dynamics
    • 6.8.4.2. Regulatory framework
    • 6.8.4.3. Competitive scenario
    • 6.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Billion)

Chapter 7. Competitive Landscape

• 7.1. Company/Competition Categorization
• 7.2. Strategy Mapping
• 7.3. Company Market Position Analysis, 2025
• 7.4. Company Profiles/Listing
  • 7.4.1. Evondos Group
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. ARxIUM
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. BD
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Capsa Healthcare
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Hero Health, Inc.
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. InstyMeds.
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. PharmRx Pty Ltd
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Swisslog healthcare
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. MedMinder Systems, Inc.
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Omnicell, Inc.
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives
  • 7.4.11. PharmaCell
    • 7.4.11.1. Company overview
    • 7.4.11.2. Financial performance
    • 7.4.11.3. Product benchmarking
    • 7.4.11.4. Strategic initiatives
  • 7.4.12. Livi Healthcare
    • 7.4.12.1. Company overview
    • 7.4.12.2. Financial performance
    • 7.4.12.3. Product benchmarking
    • 7.4.12.4. Strategic initiatives
  • 7.4.13. Philips
    • 7.4.13.1. Company overview
    • 7.4.13.2. Financial performance
    • 7.4.13.3. Product benchmarking
    • 7.4.13.4. Strategic initiatives
  • 7.4.14. LiveFine
    • 7.4.14.1. Company overview
    • 7.4.14.2. Financial performance
    • 7.4.14.3. Product benchmarking
    • 7.4.14.4. Strategic initiatives
  • 7.4.15. e-pill Medication Reminders
    • 7.4.15.1. Company overview
    • 7.4.15.2. Financial performance
    • 7.4.15.3. Product benchmarking
    • 7.4.15.4. Strategic initiatives